ArticleRheumatology (Oxford, England)2022

Ruxolitinib inhibits IFNγ-stimulated Sjögren's salivary gland MSC HLA-DR expression and chemokine-dependent T cell migration.

Sara S McCoy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.